ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

As Sequestration Hits: Varmus on Living in “Pretty Awful Times”

June 26, 2013

NIH Seeking More Women, Minorities On Committees

November 9, 1979

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975